Reply to E.R. Haspinger et al.
National Taiwan University Hospital, Taipei, Taiwan.
James Chih-Hsin
JC
Yang
Lecia V
LV
Sequist
D000230:Adenocarcinoma / Q000188:drug therapy*; D000077192:Adenocarcinoma of Lung; D000077716:Afatinib; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D066246:ErbB Receptors / Q000235:genetics*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D011799:Quinazolines / Q000627:therapeutic use*
D011799:Quinazolines; D000077716:Afatinib; D066246:ErbB Receptors